Pearls and myths in pleural fluid analysis

Virtually all patients with a newly discovered pleural effusion should undergo thoracentesis to aid in diagnosis and management. The routine pleural fluid (PF) evaluation usually includes the following: cell count and differential; tests for protein, LDH, glucose, adenosine deaminase, cytology and, if infection is a concern, pH and bacterial and mycobacterial cultures. Distinguishing transudates from exudates with Light's criteria is a pragmatic first step. If the effusion is an exudate, various PF tests have proven diagnostic utility: adenosine deaminase levels >35 IU/L usually indicate tuberculosis in lymphocyte‐predominant PF; pH < 7.2 or glucose less than 60 mg/dL allow the clinician to identify complicated parapneumonic effusions; and conventional cytology may reveal malignant cells in 60% of the patients with malignant effusions. A number of optional PF tests may complement the diagnostic approach to an undiagnosed pleural effusion. For example, natriuretic peptide assays significantly improve the accuracy of a diagnosis of cardiac pleural effusion, whereas PF mesothelin levels greater than 20 nmol/L are highly suggestive of mesothelioma.

[1]  R. Hehlmann,et al.  Diagnostic accuracy of cytology and immunocytology in carcinomatous effusions , 2008, Cytopathology : official journal of the British Society for Clinical Cytology.

[2]  R. Davies,et al.  Clinically important factors influencing the diagnostic measurement of pleural fluid pH and glucose. , 2008, American journal of respiratory and critical care medicine.

[3]  A. Dekker,et al.  Cytology of serous effusions. An investigation into the usefulness of cell blocks versus smears. , 1978, American journal of clinical pathology.

[4]  S. Bielsa,et al.  Biomarkers of heart failure in pleural fluid. , 2009, Chest.

[5]  J. M. Porcel,et al.  Contribution of a pleural antigen assay (Binax NOW) to the diagnosis of pneumococcal pneumonia. , 2007, Chest.

[6]  S. Sahn,et al.  Thoracocentesis. Clinical value, complications, technical problems, and patient experience. , 1987, Chest.

[7]  V. Villena,et al.  Clinical implications of appearance of pleural fluid at thoracentesis. , 2004, Chest.

[8]  Characteristics of pleural effusions associated with pulmonary embolism. , 1976, Archives of internal medicine.

[9]  J. M. Porcel,et al.  [Reappraisal of the standard method (Light's criteria) for identifying pleural exudates]. , 2006, Medicina clinica.

[10]  J. M. Porcel,et al.  The use of probrain natriuretic peptide in pleural fluid for the diagnosis of pleural effusions resulting from heart failure , 2005, Current opinion in pulmonary medicine.

[11]  J. Alegre,et al.  Prospective Clinical and Microbiological Study of Pleural Effusions , 1999, European Journal of Clinical Microbiology and Infectious Diseases.

[12]  R. Krenke,et al.  Incidence and aetiology of eosinophilic pleural effusion , 2009, European Respiratory Journal.

[13]  J. Rubins,et al.  Etiology and prognostic significance of eosinophilic pleural effusions. A prospective study. , 1996, Chest.

[14]  S. Martínez-Somolinos,et al.  [Utility of amylase levels in malignant pleural effusions]. , 2007, Medicina clinica.

[15]  J. M. Porcel,et al.  Antinuclear antibody testing in pleural fluid for the diagnosis of lupus pleuritis , 2007, Lupus.

[16]  J. M. Porcel,et al.  Comparing serum and pleural fluid pro‐brain natriuretic peptide (NT‐proBNP) levels with pleural‐to‐serum albumin gradient for the identification of cardiac effusions misclassified by Light's criteria , 2007, Respirology.

[17]  M. Perpiñá Tordera,et al.  Repeated Thoracentesis: An Important Risk Factor for Eosinophilic Pleural Effusion? , 2003, Respiration.

[18]  J. M. Porcel,et al.  Rentabilidad del estudio citológico del líquido pleural en el derrame maligno , 2008 .

[19]  F. Vargas,et al.  Influence of storage time and temperature on pleural fluid adenosine deaminase determination , 2006, Respirology.

[20]  P. Kvale,et al.  Volume of pleural fluid required for diagnosis of pleural malignancy. , 2002, Chest.

[21]  R. Light,et al.  Variations in pleural fluid WBC count and differential counts with different sample containers and different methods. , 2003, Chest.

[22]  J. M. Porcel,et al.  Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions. , 2004, Chest.

[23]  J. M. Porcel,et al.  Pleural fluid tests to identify complicated parapneumonic effusions , 2010, Current opinion in pulmonary medicine.

[24]  Concepción Martín,et al.  Is it meaningful to use biochemical parameters to discriminate between transudative and exudative pleural effusions? , 2002, Chest.

[25]  A. Böcking,et al.  Immunocytochemical identification of carcinomas of unknown primary in serous effusions , 2005, Diagnostic cytopathology.

[26]  P. Kvale,et al.  Prospective study to determine the volume of pleural fluid required to diagnose malignancy. , 2009, Chest.

[27]  T. Yoshida [Antinuclear antibody]. , 2020, Nihon Ishikai zasshi. Journal of the Japan Medical Association.

[28]  I. Aranda,et al.  Biochemical and cytologic characteristics of pleural effusions secondary to pulmonary embolism. , 2002, Chest.

[29]  M. Raffeld,et al.  Diagnostic effects of prolonged storage on fresh effusion samples , 2007, Diagnostic cytopathology.

[30]  E. Bateman,et al.  Utility of quantitative T-cell responses versus unstimulated interferon-γ for the diagnosis of pleural tuberculosis , 2009, European Respiratory Journal.

[31]  J. M. Porcel,et al.  Establishing a diagnosis of pleural effusion due to heart failure , 2009, Respirology.

[32]  J. M. Porcel,et al.  Diagnostic performance of adenosine deaminase activity in pleural fluid: a single-center experience with over 2100 consecutive patients. , 2010, European journal of internal medicine.

[33]  S. Pervez,et al.  Diagnostic value of clot examination for malignant cells in serous effusions , 2009, Cytopathology : official journal of the British Society for Clinical Cytology.

[34]  J. M. Porcel,et al.  Revaluación del método estándar (criterios de Light) para identificar exudados pleurales , 2006 .

[35]  J. M. Porcel,et al.  Tuberculous Pleural Effusion , 2009, Lung.

[36]  J. Jónasson,et al.  The cell block for body cavity fluids: do the results justify the cost? , 1990, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[37]  R. Light,et al.  Clinical practice. Pleural effusion. , 2002, The New England journal of medicine.

[38]  R. Light,et al.  Update on tuberculous pleural effusion , 2010, Respirology.

[39]  J. Arenas,et al.  Amylase levels in pleural effusions: a consecutive unselected series of 841 patients. , 2002, Chest.

[40]  R. Morice,et al.  Medical thoracoscopy , 2009, Current opinion in pulmonary medicine.

[41]  F. Galateau-Sallé,et al.  Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma , 2009, European Respiratory Journal.

[42]  M. Murphy,et al.  Biochemical analysis of pleural and ascitic fluid: effect of sample timing on interpretation of results , 2007, Annals of clinical biochemistry.

[43]  S. Martínez-Somolinos,et al.  Importancia de la determinación de la amilasa pleural en los pacientes con derrame neoplásico , 2007 .

[44]  F. Maldonado,et al.  Pleural fluid characteristics of chylothorax. , 2008, Mayo Clinic proceedings.

[45]  T. Morgenthaler,et al.  Low yield of microbiologic studies on pleural fluid specimens. , 2005, Chest.

[46]  M. Pratter,et al.  A prospective study of the volume of pleural fluid required for accurate diagnosis of malignant pleural effusion. , 2008, Chest.

[47]  S. Bielsa,et al.  Clinical impact and reliability of pleural fluid mesothelin in undiagnosed pleural effusions. , 2009, American journal of respiratory and critical care medicine.

[48]  J. M. Porcel,et al.  [Parapneumonic pleural effusions and empyema in adults:current practice]. , 2009, Revista clinica espanola.

[49]  N. Langeland,et al.  Adenosine Deaminase Activity Is a Sensitive Marker for the Diagnosis of Tuberculous Pleuritis in Patients with Very Low CD4 Counts , 2008, PloS one.

[50]  M. Odida,et al.  Evaluation of suspected tuberculous pleurisy: clinical and diagnostic findings in HIV-1-positive and HIV-negative adults in Uganda. , 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[51]  R. Light,et al.  Analysis of pleural effusions in acute pulmonary embolism: Radiological and pleural fluid data from 230 patients , 2007, Respirology.

[52]  Sharangouda J. Patil,et al.  The sensitivity of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma , 2010, Diagnostic cytopathology.

[53]  N. Kurata [Adenosine deaminase]. , 2020, Nihon rinsho. Japanese journal of clinical medicine.

[54]  T. Chandler,et al.  Comparison of the use and accuracy of methods for determining pleural fluid pH. , 1999, Southern medical journal.